Ver mas grande
AGER antibody
FT-FNab10403
Producto nuevo
100 µg
Comprando este producto generará 1 Biopunto. Su cesta contiene un total 1 Biopunto puede ser convertido en un Biobonos Descuento 4.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB, IHC |
| Target | AGER |
| Research Area | Immunology, Signal Transduction, Developmental biology |
| Form | liquid |
| Recomended Dilution | WB: 1:200-1:2000 |
| Type Clonality | polyclonal |
| Immunogen | advanced glycosylation end product-specific receptor |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | Advanced glycosylation end product-specific receptor|Receptor for advanced glycosylation end products|AGER|RAGE |
| Host | Rabbit |
| UniProt ID | Q15109 |
| Gene ID | 177 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human, Mouse, Rat |
| Observed MW | 40-55 kDa |
| Background | Mediates interactions of advanced glycosylation end products(AGE). These are nonenzymatically glycosylated proteins which accumulate in vascular tissue in aging and at an accelerated rate in diabetes. Acts as a mediator of both acute and chronic vascular |
Más información
AGER antibody